Early administration of AAV-Sbno1 to stroke mice could inhibit the further worsening of the disease caused by neuroinflammation and improve prognosis by enhancing the endogenous repair capabilities of neural stem cells (Fig. 7). The gene discussed is SBNO1; the disease is stroke disorder.